Introduction
Hydrogen peroxide, a secretory product of activated macrophages and granulocytes, lyses murine tumor cells under some experimental conditions (1) . A major defense of murine tumors against lysis by H202 is the glutathione (GSH)' redox cycle (2-4). Thus, threefold to 10-fold smaller fluxes of H202 were required to lyse tumor cells after inhibition of their GSH peroxidase by deprivation of selenium (2), inactivation of GSSG reductase with 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU) (2), blockade of y-glutamylcysteine synthetase with 1. Abbreviations used in this paper: AT, 3-amino-1,2,4-triazole; BCNU, 1,3-bis(2-chlorethyl)-l-nitrosourea; BSO, buthionine sulfoxiinine; FBS, heat-inactivated fetal bovine serum; GR, glutathione reductase; GSH, glutathione; KRPG, Krebs-Ringer phosphate buffer containing 7 .2 mM phosphate and 5.5 mM glucose; LD", 50% specific lysis; M-5% HS, a-modified Eagle's minimal essential medium with 5% heatinactivated horse serum; M-S, a-modified Eagle's minimal essential medium with 0.1 mM nonessential amino acids, 15% FBS and 100 U/ml penicillin and 100 .g/ml streptomycin; MEM, minimal essential medium; P/S2, 100 U/ml penicillin, 100 ug/ml streptomycin; R-S, RPMI 1640 medium supplemented with I mM pyruvate, 300 ,g/ml glutamine, 0.1 mM nonessential amino acids, 100 U/ml penicillin, 100 ,g/ml streptomycin, and heat-inactivated FBS. buthionine sulfoximine (BSO) (3), or acute GSH depletion with chlorodinitrobenzene (3) or sulthydryl-reactive natural products including sesquiterpene lactones (4). In contrast, murine tumor cell catalase seemed to play a secondary role in defense against oxidative lysis (2, 3) .
In this report, we have attempted to define which reactive oxygen intermediates are rapidly lytic for various human cells (mostly tumors) and at what concentrations, to correlate relative resistance with the activity of the GSH redox cycle and catalase, and to analyze the role of these antioxidant enzymes in the consumption of H202 by intact cells and in the resistance of the cells to lysis by H202. The results indicate that the specific activities of catalase and the GSH redox cycle components in cell lysates predict neither the H202 consumption nor the resistance of the intact cell. Moreover, H202 consumption and resistance can occur by apparently different mechanisms. These findings may be relevant for pathophysiologic concepts and therapeutic designs based on oxidant injury of human cells.
Methods
Cells. Three breast adenocarcinoma cell lines were used. SK-BR-1-III, derived from a pleural effusion (5) , was grown as a suspension in RPMI 1640 medium (KC Biologicals, Lenexa, KS) supplemented with 1 mM pyruvate, 300 ug/ml glutamine, 0.1 mM nonessential amino acids, 100 U/ml penicillin, 100 ug/ml streptomycin (P/S2) (Gibco Laboratories, Grand Island, NY), and 20% heat-inactivated fetal bovine serum (FBS20) (HyClone Laboratories, Logan, UT). This medium is designated R-S. SK-BR-2-III, explanted from ascites, was grown in suspension in R-S. CAMA-I, from a pleural effusion, was grown as a monolayer in a-modified Eagle's minimum essential medium (KC Biologicals) with 0.1 mM nonessential amino acids, 15% heat-inactivated fetal bovine serum (FBS), and P/S2. This medium is designated M-S. SK-OV-3, an ovarian adenocarcinoma cell line derived from ascites a different donor as the cell source. Mouse mastocytoma (P815) and lymphoma cells (L1210, P388, TLX9) were as described (2, 9).
Cytolysis assay. To determine susceptibility to lysis by H202, nonadherent cells, usually numbering 2-5 X 106, were suspended in 2 ml a-modified minimal essential medium (MEM)-5% heat-inactivated horse serum (HyClone Laboratories) (M-5% HS) with 200 ACi of Na251'CrO4 (New England Nuclear, Boston, MA), incubated at 370C in 5% C02/95% air for 60 min, and washed four times by centrifugation in M-5% HS. Cell concentration and viability were determined by counting trypan blue-excluding cells in a hemocytometer. 4 X 104 "Cr-labeled cells in 0.2 ml M-5% HS were added to round-bottomed microtest plate wells (Linbro Division, Flow Laboratories, McLean, VA) containing graded amounts of H202 (Superoxol; Fisher Chemical Co., Fairlawn, NJ) or glucose oxidase (Sigma Chemical Co., St. Louis, MO), diluted in 0.9% NaCl. When glucose oxidase was used, the glucose concentration was raised to 40 mM. H202 generated by glucose oxidase was measured using the 02 monitor as described below for H202 consumption. Plates were incubated at 370C in 5% C02/95% air for 3 h. For murine tumor cells, non-a-modified MEM was used as before (9) . After centrifugation at 550 g for 5 min, 0.1 ml supernate was removed for gamma counting. Results were similar when the assay time was extended to 4.5, 6, or 16 h, or when 5% horse serum was replaced with 5% human serum or 0.005% gelatin (Fisher Chemical Co.). For adherent cells, 2 X 10' cells were plated on 13-mm diam glass coverslips in 24-well Costar plates (Data Packaging, Inc., Cambridge, MA), labeled by the addition of I ml M-5% HS containing 2 MCi Na25'CrO4 for 60 min at 37°C in 5% C02/95% air, and washed four times in M-5% HS. The cells were then incubated in I ml M-5% HS with or without H202 for 3 h, centrifuged as above, and 0.5 ml supernate was removed as sample. The residual supernate was pooled with the 0.5 N NaOH lysate of the remaining cells and both the sample and residual were used for gamma counting. The concentration of H202 causing 50% specific lysis (LD".) was calculated by interpolation as previously described (9) . Determination of cell susceptibility to lysis by superoxide and hydroxyl radicals was performed as above with modifications to reduce the scavenging effect of serum on these oxygen intermediates. "Cr-labeled cells were placed in serum-coated borosilicate glass tubes (12 X 75 mm) in Krebs-Ringer phosphate buffer containing 7.2 mM phosphate and 5.5 mM glucose (KRPG) (8) in the presence of graded amounts of K02 (Sigma Chemical Co.), or H202 together with an equimolar amount of FeSO4 (chelated by a threefold molar excess of EDTA) (Sigma Chemical Co.) for 30 min at 37°C in air. M-5% HS was then added and the tubes were incubated in 5% C02/95% air for an additional 2 h to allow for completion of the "Cr release. Adherent cells were treated similarly except that cell-bearing coverslips were placed in serum-coated 24-well plates. Effects of OI-were determined by a 3-h incubation in microtest plates of 4 X 106 cells in 200 Ml KRPG containing 0.005% gelatin together with lactoperoxidase (Sigma Chemical Co.), iodide, and H202 as indicated. Lysis as estimated by the specific release of "Cr was closely comparable to lysis estimated from hemocytometer counts of cells excluding 0.2% trypan blue.
Biochemical assays. Total cell glutathione (GSH plus GSSG) was measured according to Tietze (10) (14) , NADH by a modified method of Avigad (15) , and ascorbate as described (16) . Protein was determined by the method of Lowry et al. (17) with bovine serum albumin as the standard. H202 was measured by the horseradish peroxidase-catalyzed oxidation of fluorescent scopoletin (8), O-by the superoxide dismutaseinhibitable reduction offerricytochrome c (8) , and OH by the production of formaldehyde from dimethylsulfoxide (18) . H202 consumption. Cells were incubated at 370C in 5% C02/95% air at I X 106 cells/ml M-5% HS for nonadherent cells and -5 X 106 cells per coverslip in I ml M-5% HS for adherent cells. At time 0, 5 mM H202 was added. At 0, 30, 60, and 180 min, the H202 concentration was determined on aliquots by a modification of the method of Schroy and Biaglow (19) . The oxygen electrode system described above was calibrated with air-saturated PBS. 2.8 ml PBS containing 200 U/ml bovine liver catalase (Sigma Chemical Co.) were purged with N2. A 200-ul aliquot of the reaction medium was added with a Hamilton syringe and the generation of 02 was followed to completion. H202 was calculated as twice the generated 02.
Enzyme inhibitors. Sodium azide (Fisher Chemical Co.) was dissolved in 0.9% NaCl and added to cells at 0.5 mM immediately before assay. 3-amino-1,2,4-triazole (AT; Sigma Chemical Co.) was dissolved in M-5% HS and added to cells at 50 mM for 60 min during "Crlabeling as well as during assays. BSO (Chemical Dynamics Corp., S. Plainfield, NJ) was dissolved in H20 at 20 mM and cells were exposed to 0.2 mM BSO for 17 h before "Cr-labeling and throughout the assays. BCNU (Bristol Laboratories, Syracuse, NY) was dissolved in absolute ethanol at 100 mg/ml, diluted to 1 mg/ml in MEM, and added to cells at 100 Ag/ml for the last 10 min of "Cr-labeling.
Results
Identification ofcytolytic oxygen reduction products. To determine which extracellularly generated oxygen reduction products rapidly lyse human cells, and therefore which enzymes might be involved in defense against oxidative cytolysis, we compared the susceptibility of fibroblasts, SK-BR-1-III, SK-BR-2-III, erythrocytes, and CAMA-I to H202,°-, and OH. Lysis first was attempted with the H202 generating system of glucose oxidase and glucose, which lysed most murine tumors tested (1) . However, fluxes of H202 (nanomoles per minute per 0.2 ml) up to 3 for fibroblasts, 14 for SK-BR-l-III, 15 for SK-BR-2-Ill, 21 for erythrocytes, and 105 for CAMA-I failed to produce substantial lysis (not shown). Consistent with this, there was no significant lysis of SK-BR-2-III or fibroblasts by phorbol myristate acetate-stimulated human granulocytes or monocytes at a 10-fold or 20-fold excess over target cells during 6 h of co-incubation (not shown). We therefore tested these cells' susceptibility to preformed H202. As shown in Fig.  I for SK-BR-2-III, H202 was lytic in a dose-dependent, catalaseinhibitable manner. 50% lysis by 3 h required 1.2 mM H202. Results were similar with the other four cell types.
We next attempted to lyse these cells with the 02-generating system of xanthine oxidase and acetaldehyde. Using each agent at the maximal nontoxic concentration, only gM concentrations of O2 were detected. As these concentrations were not cytolytic, we employed preformed O-(as K02). Fig. 1 To generate OH', we added EDTA-chelated FeSO4 to H202. This resulted in rapid loss of H202 and generation of formaldehyde from added dimethylsulfoxide (18) , indicating the production of at least micromolar concentrations of OH'. However, as shown in Fig. 1 for SK-BR-2-III, only marginal cell lysis was attained with these reagents, and this could be reproduced with EDTA-chelated FeSO4 alone. Results were similar with CAMA-I and erythrocytes. The sensitivity of fibroblasts to H202, however, was enhanced by EDTA-FeSO4 and this enhancement was abolished by catalase, suggesting that this cell type was susceptible to OH' derived from H202.
As first shown for bacteria by Klebanoff (21) and for mammalian cells by Edelson and Cohn (22) , the hypohalite generated by H202, peroxidase, and halide is extremely cytotoxic. Table I illustrates the finding that H202-dependent lysis of SK-BR-2-III was augmented 100-fold by lactoperoxidase and iodide. Catalase prevented lysis. Azide, which was expected to inhibit lactoperoxidase, nonetheless augmented lysis twoto threefold. The tumor cells seemed to be using an azidesensitive pathway for protection against H202.
The foregoing results suggested that the more reduced forms of 02, primarily H202 and 10-, and in some cases OH, were lytic to human cells, while the less reduced 0°was not. As there is no known enzymatic defense against I0-or OH', we next focused on the cells' enzymatic defenses against H202.
Quantification ofsusceptibility ofhuman cells to H202 and relation to levels of catalase, GSH redox cycle components, and other peroxidases. Study of human cell susceptibility to and defense against H202 was undertaken with the following cell types: three breast adenocarcinomas, of which two (SK-BR-2-III and SK-BR-1-III) were nonadherent and one (CAMA-I) was adherent, an adherent ovarian adenocarcinoma (SK-OV-3), a nonadherent B cell line (B0467), a nonadherent leukemic T cell line (HSB), an adherent, contact-inhibited diploid skin fibroblast line (CCD-21-SK), erythrocytes, and peripheral blood lymphocytes. All nine of these human cell types exhibited far greater resistance to lysis by H202 than previously studied murine cells, with LD50s ranging from 2 to 20 mM (Table II) . In contrast to a number of earlier reports on oxidative lysis of human cells, these experiments were conducted in media of physiologic tonicity, pH, and glucose concentration.
Several potential scavengers of H202 were measured in each cell type (Table II) Identpication of H20-consuming pathways. Although it was assumed that degradation of H202 was the primary defense of cells against it, the possibility was considered that different pathways might be involved in resistance to and degradation of H202. The rate of H202 consumption with or without prior exposure to BSO (to deplete GSH) and azide (to inhibit catalase) was therefore measured in five cell types. The results for four of them are displayed in Fig. 2 . 17 h pretreatment with BSO had no effect on the cells' capacity to consume 5 mM H202 over a 3 h period. In contrast, azide inhibited H202 consumption by an average of 90%. Results with BSO plus azide were the same as with azide alone. Similar results were seen with B0467, a cell line whose LD50 for H202 was unaffected by azide (Table III) . Thus, all five cell types tested appeared to utilize an azide-sensitive mechanism (probably catalase) almost exclusively to catabolize millimolar concentrations of extracellular H202.
Discussion
We conclude from this study that all nine human cell types tested were markedly resistant to lysis by H202 (with LD50s in the 2-20 mM range), that under appropriate experimental conditions, resistance to H202 could be manifest in the absence of its detectable consumption, and that the specific activity or content of the primary known H202 scavenging systems (catalase and the GSH redox cycle) did not predict which of them, if either, played a major role in resistance to H202-mediated cytolysis in a given cell. These findings have implications for pathophysiologic and therapeutic concepts involving oxidative cellular injury and its pharmacologic control. We focused on resistance to and degradation of H202 because preliminary studies identified H202 as the only enzymatically degradable 02 reduction product capable of rapidly lysing the cells under study. The toxicity of H202 rather than O-under these conditions agrees with prior studies on fibroblasts (26) and lymphocytes (27 (19) , as well as for lymphocytes (27) , granulocytes (36) , and platelets (36) . Our present study revealed that human cell degradation of H202 was rapid (mean initial rate, 84 nmol H202/min per mg cell protein with initial [H2021 = 5 mM) and almost completely inhibitable by 0.5 mM NaN3, presumably reflecting the predominant role of catalase under these conditions. Yet, the rate of azide-inhibitable H202 consumption by a given cell type was not correlated with the specific activity of its catalase as measured in 0.2% Triton X-100 cell lysates (correlation coefficient, -0.71). This emphasizes that assays of enzymes in lysates may not closely predict their function in intact cells. The unlikely possibility exists that an azide-sensitive enzyme other than catalase was responsible for most of the H202 consumption.
More important, virtually complete inhibition of detectable H202 consumption did not sensitize the cells to destruction by all but millimolar quantities of H202. This demonstrates that resistance to the toxicity of H202 can have a biochemical basis distinct from catabolic pathways that perceptibly lower the extracellular concentration of H202. It is therefore clear that the cell types studied exhibited an inherent resistance to lysis by H202 even when their ability to consume H202 was impaired. In theory, the GSH redox cycle could function either to degrade H202 or to reduce lipid peroxides. The latter action would repair cellular injury rather than prevent it, and might be manifest as a resistance to peroxidative lysis out of proportion to consumption of peroxide. However, as noted below, a prominent role for the GSH redox cycle in resistance to H202-mediated cytolysis was shown in only one of the nine cell types studied.
In contrast to the predominance of an azide-sensitive mechanism (probably catalase) in degradation of millimolar H202 in all the human cell types tested, resistance of the cells to lysis by millimolar H202 during 3 h of exposure was attributable in part to the GSH redox cycle in two cell lines, catalase in seven cell lines, and neither in two others. These interpretations are based on the degree to which the cells were sensitized to H202 by pharmacologic agents directed against GSH, GR, or catalase. These patterns could not be predicted either from the LD50 of H202 for a given cell type nor from the specific activity or content of the enzymes and substrates involved. These results are consistent with those of Marklund et al. (30) , who found no correlation between sensitivity to ionizing radiation or oxygen radical-producing drugs and levels of catalase, GPO, or superoxide dismutase in 46 normal and neoplastic cell types.
We do not understand the biochemical basis for resistance to millimolar H202 on the part of the human cell types studied here. We have not yet measured certain nonenzymatic antioxidants, such as ascorbate and tocopherol (37) . It seems critical to identify the molecular targets whose oxidation by H202 leads to rapid cell death, and to measure the pool sizes and rates of regeneration of these molecules at rest and during oxidative stress. Another unknown is the role of the subcellular localization of antioxidant defense systems in relation to the critical targets of oxidative injury. Finally, the 5"Cr-release 84 J. O'Donnell-Tormey, C. J. DeBoer, and C. F. Nathan (47) . Thus, the genern distinction drawn here between large numbers of unselecte murine and human cell types does not reflect an absolut species difference.
Indeed, it is of interest that certain normal human ce types seem to be much more sensitive to oxidative injury tha the cells studied here. Weiss et al. (48) showed that huma umbilical vein endothelial cells were sensitive to lysis by H2C released from stimulated neutrophils. The concentration c H202 generated by the neutrophils was 67 ,M, 1 (26) . Even in our study, where human fibroblasts were insensitive to fluxes of H202 attainable with glucose oxidase or xanthine oxidase, the cells were rendered up to 20-fold more sensitive to H202 by inhibition of the GSH redox cycle with BSO or BCNU. Thus, the possibility remains that endothelial cells or other components of tumor vasculature might be suitable targets for the localized delivery of oxidant stress to the tumor bed, in conjunction with pharmacologic inhibition of the GSH redox cycle (3, 4). 
